Osmotica Pharmaceuticals plc Reports Third Quarter 2021 Results and Provides Business Update

Provided By Globe Newswire

Last update: Nov 15, 2021

Third quarter Upneeq® product sales of $2.2 million, representing 47% growth over second quarter sales

Expansion of Upneeq launch continues with introduction of Direct Dispense program in eyecare and formation of Aesthetics business unit